These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15699230)

  • 1. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.
    Rafii M; Chapman K; Stewart C; Kelly E; Hanna A; Wilson DC; Tullis E; Pencharz PB
    Am J Clin Nutr; 2005 Feb; 81(2):421-6. PubMed ID: 15699230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
    Moran A; Pekow P; Grover P; Zorn M; Slovis B; Pilewski J; Tullis E; Liou TG; Allen H;
    Diabetes Care; 2009 Oct; 32(10):1783-8. PubMed ID: 19592632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
    Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
    Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
    Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cystic fibrosis-related diabetes on health-related quality of life.
    Kwong E; Desai S; Chong L; Lee K; Zheng J; Wilcox PG; Quon BS
    J Cyst Fibros; 2019 Sep; 18(5):734-736. PubMed ID: 30935840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
    Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
    J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
    Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
    BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes in cystic fibrosis.
    Bridges N
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():16-8. PubMed ID: 23522600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of cystic fibrosis-related diabetes.
    Brennan AL; Geddes DM; Gyi KM; Baker EH
    J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus in patients with cystic fibrosis.
    Alves Cde A; Aguiar RA; Alves AC; Santana MA
    J Bras Pneumol; 2007; 33(2):213-21. PubMed ID: 17724542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance.
    Bizzarri C; Lucidi V; Ciampalini P; Bella S; Russo B; Cappa M
    J Endocrinol Invest; 2006 Mar; 29(3):RC1-4. PubMed ID: 16682829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exogenous insulin on protein metabolism with differing nonprotein energy intakes in Type 2 diabetes mellitus.
    Gougeon R; Marliss EB; Jones PJ; Pencharz PB; Morais JA
    Int J Obes Relat Metab Disord; 1998 Mar; 22(3):250-61. PubMed ID: 9539194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.